Daniel was Head Global Medical Affairs, Rare Disease for Sanofi Genzyme. Daniel Gruskin joined LogicBio Therapeutics in 2020. Daniel served as Interim Head of Clinical Development at LogicBio Therapeutics.Daniel Gruskin is currently
Create an alert
to follow the career of Daniel Gruskin.
Do you need to know more about Daniel Gruskin? Extend your search.
At LogicBio Therapeutics, Daniel Gruskin has 1 colleague who can be contacted.Industry Colleagues
In the Biotechnology industry, Daniel Gruskin has 20,116 colleagues in 1,677 companies located in 40 countries. 12,024 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Learn about your clients' org charts. Understand their industries and their competitors.
View the executives' biographies. Contact the executives through our email platform.
Select key words to follow your clients. Receive alerts when executive movements happen.
File your clients in folders. Add private notes. Download our data in Excel on your PC.